RETINVUE
Live / Allowed — Fifth extension granted (statement of use) (as of 12 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 19 Jun 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98048437
- Mark type
- Word mark
- Filed
- 19 Jun 2023
- Published for opposition
- 31 Oct 2023
- Attorney of record
- Kimberly Jarman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of eye diseases and conditions
Owner
- EYEPOINT US, INC., WATERTOWN, MA, US
- EyePoint Pharmaceuticals US, Inc., Watertown, MA, US
- EyePoint Pharmaceuticals US, Inc., Watertown, MA, US
Prosecution history
- 13 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Aug 2026 — SOU EXTENSION 5 GRANTED
- 19 May 2026 — SOU EXTENSION 5 FILED
- 12 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 May 2026 — SOU TEAS EXTENSION RECEIVED
- 11 Mar 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 02 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Dec 2025 — SOU EXTENSION 4 GRANTED
- 02 Dec 2025 — SOU EXTENSION 4 FILED
- 02 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jun 2025 — SOU EXTENSION 3 GRANTED
- 09 Jun 2025 — SOU EXTENSION 3 FILED
- 09 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 09 Dec 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED